Baxalta (United States)

Baxalta (United States)

Baxalta is a biopharmaceutical company founded on 1 July 2015 after its parent company, Baxter International, spun off biopharmaceutical division. The company began its operation with a revenue of $6 billion, and is now a subsidiary of Takeda Pharmaceutical Company. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Baxalta (United States), United States, covering academic research published from 2001 to 2024. Read More.


Open Access Percentage

39%


Total
Publications

301


Total Open
Publications

118


Total
Citations

6.7K


Open Access
Percentage

39%


Total
Publications

301


Total Open
Publications

118


Total
Citations

6.7K

Wikipedia

Website

download

Breakdown

19% 17% 2% 62%

Publisher Open

19%

Both

17%

Other Platform Open

2%

Closed

62%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090Total Publications
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

20%OA Journal

OA Journal 20%

21

Hybrid 41%

43

No Guarantees 39%

40

Other Platform Open

Domain 80%

45

Other Internet 18%

10

Institution 16%

9

Preprint 2%

1

Public 2%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
45
DOI
Other Internet
10
São Paulo State University - UNESP Institutional Repository
Institution
2
DANS - Data Archiving and Networked Services
Institution
2
University of Michigan - Deep Blue
Institution
1
University of Bristol - Bristol Research
Institution
1
uchile.cl OAI-PMH Repository
Institution
1
Servicio Gallego de Salud (SERGAS - RUNA. Repositorio Institucional del Sergas)
Institution
1
Research Square
Preprint
1
ORA - Oxford University Research Archive
Institution
1
1 / 2

Data updated 18 August 2025

Share

Share

Share